FDA NDC Directory · JSON-LD · Markdown

Alfuzosin Hydrochloride

NDC 60505-2850 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA079013
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsALFUZOSIN HYDROCHLORIDE (10 mg/1)
Marketing started20230908
Package count1

External sources

Source: openFDA. Public-domain (CC0).